GDGoberdhan P. Dimri

Goberdhan P. Dimri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Goberdhan P. Dimri has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Jacqueline J. L. Jacobs

    Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands

    2 shared publications
  • Koji Itahana

    Programme in Cancer and Stem Cell Biology Duke‐NUS Medical School Singapore

    2 shared publications
  • Christian Beausejour

    Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720,1 California Pacific Medical Center, San Francisco, California 94115,2 Division of Radiation and Cancer Biology, Department of Radiation Oncology, New England Medical Center, Boston, Massachusetts 02111,3 Division of Molecular Genetics, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands4

    1 shared publication
  • David E. Wazer

    Department of Radiation Oncology, New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA

    1 shared publication
  • Jose-Luis Martinez

    1 shared publication
  • José-Luis Martínez-Guitarte

    Department of Mathematical Physics and Fluids, Faculty of Sciences, National Distance Education University (UNED), Madrid, Spain

    1 shared publication

Latest Publications

  • Open Access

    Control of the Replicative Life Span of Human Fibroblasts by p16 and the Polycomb Protein Bmi-1

    by Koji Itahana, Ying Zou, Yoko Itahana, Jose-Luis Martinez, Christian Beausejour, Jacqueline J. L. Jacobs, Maarten van Lohuizen, Vimla Band, Judith Campisi, Goberdhan P. Dimri

    The polycomb protein Bmi-1 represses the INK4a locus, which encodes the tumor suppressors p16 and p14ARF. Here we report that Bmi-1 is downregulated when WI-38 human fibroblasts undergo replicative senescence, but not quiescence, and extends replicative life span when overexpressed. Life span extension by Bmi-1 required the pRb, but not p53, tumor suppressor protein. Deletion analysis showed that the RING finger and helix-turn-helix domains of Bmi-1 were required for life span extension and suppression of p16. Furthermore, a RING finger deletion mutant exhibited dominant negative activity, inducing p16 and premature senescence. Interestingly, presenescent cultures of some, but not all, human fibroblasts contained growth-arrested cells expressing high levels of p16 and apparently arrested by a p53- and telomere-independent mechanism. Bmi-1 selectively extended the life span of these cultures. Low O2 concentrations had no effect on p16 levels or life span extension by Bmi-1 but reduced expression of the p53 target, p21. We propose that some human fibroblast strains are more sensitive to stress-induced senescence and have both p16-dependent and p53/telomere-dependent pathways of senescence. Our data suggest that Bmi-1 extends the replicative life span of human fibroblasts by suppressing the p16-dependent senescence pathway.


    • 15 August 2002
      • Vol. 62  (16) , 4736-45

    The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells.

    by Goberdhan P Dimri, Jose-Luis Martinez, Jacqueline J L Jacobs, Petra Keblusek, Koji Itahana, Maarten Van Lohuizen, Judith Campisi, David E Wazer, Vimla Band

    The vast majority of breast cancers are carcinomas that arise from mammary epithelial cells (MECs). One of the key early events in tumorigenic transformation is the ability of cells to overcome replicative senescence. However, the precise genetic changes that are responsible for this event in MECs is largely unknown. Here, we report that Bmi-1, originally identified as a c-Myc cooperating oncoprotein, can bypass senescence, extend the replicative life span, and immortalize MECs. Furthermore, Bmi-1 was overexpressed in immortal MECs and several breast cancer cell lines. Overexpression of Bmi-1 in MECs led to activation of human telomerase reverse transcriptase (hTERT) transcription and induction of telomerase activity. Telomerase induction by Bmi-1 was an early event in the extension of the replicative life span and immortalization. Bmi-1 was not overexpressed in hTERT-immortalized MECs, suggesting that Bmi-1 functions upstream of hTERT. Although, c-Myc has been reported to induce telomerase in MECs, Bmi-1 appeared to act independently of c-Myc binding sequences in the hTERT promoter. Deletion analysis of the Bmi-1 protein suggested that the RING finger, as well as a conserved helix-turn-helix-turn domain, were required for its ability to induce telomerase and immortalize MECs. These data suggest that Bmi-1 regulates telomerase expression in MECs and plays a role in the development of human breast cancer.